CLINICAL_TRIALS
trial_result
· 2025-04-27
Clinical Trial Update: A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings [Phase 4]
Summary
Phase 4 study evaluating paliperidone palmitate for schizophrenia in Rwanda has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen-Cilag International NV | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED